Drug Shortage Report for MYLAN-BUDESONIDE AQ
Report ID | 23166 |
Drug Identification Number | 02230648 |
Brand name | MYLAN-BUDESONIDE AQ |
Common or Proper name | BUDESONIDE AQ |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | BUDESONIDE |
Strength(s) | 100MCG |
Dosage form(s) | SPRAY, METERED DOSE |
Route of administration | NASAL |
Packaging size | 165 |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-04-16 |
Actual start date | 2018-04-16 |
Estimated end date | 2020-01-30 |
Actual end date | 2020-01-20 |
Shortage status | Resolved |
Updated date | 2020-01-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v132 | 2020-01-21 | French | Compare |
v131 | 2020-01-21 | English | Compare |
v130 | 2020-01-13 | French | Compare |
v129 | 2020-01-13 | English | Compare |
v128 | 2019-10-01 | French | Compare |
v127 | 2019-10-01 | English | Compare |
v126 | 2019-09-03 | French | Compare |
v125 | 2019-09-03 | English | Compare |
v124 | 2019-08-23 | French | Compare |
v123 | 2019-08-23 | English | Compare |
v122 | 2019-08-07 | French | Compare |
v121 | 2019-08-07 | English | Compare |
v120 | 2019-07-23 | French | Compare |
v119 | 2019-07-23 | English | Compare |
v118 | 2019-07-16 | French | Compare |
v117 | 2019-07-16 | English | Compare |
v116 | 2019-07-03 | French | Compare |
v115 | 2019-07-03 | English | Compare |
v114 | 2019-06-18 | French | Compare |
v113 | 2019-06-18 | English | Compare |